Cabergoline is a prescription medication classified as an ergot derivative and dopamine receptor agonist.

What Are the Indications for Cabergoline?

Primary Indications

Cabergoline is approved in the United States for the treatment of disorders associated with hyperprolactinemia.

Specifically, it is indicated for adult patients with hyperprolactinemia caused by pituitary adenomas (regardless of size) or of unknown etiology (idiopathic).

Important Usage Restrictions

It must be emphasized that cabergoline should not be used to suppress or terminate physiological postpartum lactation.

To avoid the risk of serious adverse reactions (such as hypertension, stroke, myocardial infarction, seizures, and even death), the use of this medication for this purpose should be strictly prohibited.

Core Treatment Objectives

Within the scope of its approved indications, the goal of cabergoline therapy is to reduce and maintain the patient’s serum prolactin levels within the normal range.

Its efficacy has been confirmed in clinical studies, which demonstrated its ability to effectively normalize prolactin levels, restore menstrual cycles, and eliminate galactorrhea.

Dosage Form, Strength and Description of Cabergoline

Dosage Form and Strength

Cabergoline is supplied as oral tablets, with a strength of 0.5 mg per tablet.

Appearance Description

The tablets are white and capsule-shaped.

One side of the tablet is marked with a functional score line (facilitating accurate splitting for half-dose administration), with the letters "P" and "U" printed on either side of the score line. The reverse side of the tablet is engraved with the number "700".

Composition

Each cabergoline tablet contains 0.5 mg of cabergoline as the active ingredient.

Inactive excipients include leucine and lactose. Patients with lactose intolerance should exercise caution before administration.

Storage and Handling Requirements for Cabergoline

Storage Conditions

To ensure the stability and effectiveness of the medication, cabergoline tablets should be stored in a tightly sealed container at room temperature, ranging from 20°C to 25°C (68°F to 77°F).

Exposure to excessive heat, cold, or humidity should be avoided.

Packaging and Handling

The medication should always be kept in its original container to provide optimal protection against light and moisture.

The bottle cap should be tightly closed immediately after each use.

Safety Precautions

Like all other medications, cabergoline must be stored out of the reach and sight of children to prevent accidental ingestion.

Do not use the medication beyond its expiry date, and do not administer it for any purposes other than those specified in the prescription.